Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
RESPONSE BIOMEDICAL CORP (RBM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/02/2016 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 12/02/2016 |
8-K
| Quarterly results |
| 12/01/2016 |
4
| Kinnaird-Steen Barbara (CEO) has filed a Form 4 on RESPONSE BIOMEDICAL CORP |
| 12/01/2016 |
4
| HOLLER ANTHONY F (Director) has filed a Form 4 on RESPONSE BIOMEDICAL CORP |
| 12/01/2016 |
4
| KEEGAN JOSEPH D (Director) has filed a Form 4 on RESPONSE BIOMEDICAL CORP |
| 12/01/2016 |
4
| Shuster Lewis (Director) has filed a Form 4 on RESPONSE BIOMEDICAL CORP |
| 12/01/2016 |
4
| SEVERSON CLINTON (Director) has filed a Form 4 on RESPONSE BIOMEDICAL CORP |
| 12/01/2016 |
4
| Adams William J. (CFO & Corporate Secretary) has filed a Form 4 on RESPONSE BIOMEDICAL CORP |
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on RESPONSE BIOMEDICAL CORP |
| 12/01/2016 |
4
| Wang Jonathan Jian (10% Owner) has filed a Form 4 on RESPONSE BIOMEDICAL CORP |
| 12/01/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/01/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/01/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/01/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/01/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/01/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/30/2016 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 11/15/2016 |
8-K
| Form 8-K - Current report |
| 11/14/2016 |
10-Q
| Quarterly Report for the period ended September 30, 2016 |
| 08/16/2016 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/16/2016 |
8-K
| Quarterly results |
| 08/15/2016 |
10-Q
| Quarterly Report for the period ended June 30, 2016 |
| 08/11/2016 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers [Amend] |
| 08/11/2016 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 08/04/2016 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers [Amend] |
| 08/04/2016 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials |
| 07/25/2016 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers [Amend] |
| 07/25/2016 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials |
| 06/24/2016 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition |
| 06/20/2016 |
4
| Wang Jonathan Jian (10% Owner) has filed a Form 4 on RESPONSE BIOMEDICAL CORP|
Txns:
| Bought 556,339 shares
@ $0.56, valued at
$311.5k
Bought 5,294 shares
@ $0.56, valued at
$3k
Bought 331,225 shares
@ $0.56, valued at
$185.5k
|
|
| 06/20/2016 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on RESPONSE BIOMEDICAL CORP|
Txns:
| Bought 556,339 shares
@ $0.56, valued at
$311.5k
Bought 5,294 shares
@ $0.56, valued at
$3k
Bought 331,225 shares
@ $0.56, valued at
$185.5k
|
|
| 06/20/2016 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on RESPONSE BIOMEDICAL CORP|
Txns:
| Bought 556,339 shares
@ $0.56, valued at
$311.5k
Bought 5,294 shares
@ $0.56, valued at
$3k
Bought 331,225 shares
@ $0.56, valued at
$185.5k
|
|
| 06/20/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
|
|
|